In this report, we demonstrated that SRSF3 at its physiological level functions as a tumor-promotor in development of Erbb2 breast cancer, but a tumor-suppressor in DEN-induced liver cancer, through regulation of RNA transcription or alternative splicing of a different set of genes. This evidence concerns the gene ERBB2 and liver cancer.